Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
Surgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approac...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2025-01-01
|
Series: | The Arab Journal of Interventional Radiology |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791222 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832583138116632576 |
---|---|
author | Ahmed Kamel Abdel Aal Juri Bassuner Husameddin El Khudari Reema F. Alrasheed Shahroz Aziz Mohamed Shahin Ammar Almehmi Bridget Kowalczyk |
author_facet | Ahmed Kamel Abdel Aal Juri Bassuner Husameddin El Khudari Reema F. Alrasheed Shahroz Aziz Mohamed Shahin Ammar Almehmi Bridget Kowalczyk |
author_sort | Ahmed Kamel Abdel Aal |
collection | DOAJ |
description | Surgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approaches have led to the development of percutaneous arteriovenous fistula creation. Currently, there are two Food and Drug Administration (FDA) approved systems, namely WavelinQ and Ellipsys. The aim of this article is to review the available literature on the outcomes of percutaneous arteriovenous fistula creation. Studies have reported high technical success rates for both the WavelinQ and Ellipsys systems. However, re-interventions were necessary for maturation, maintenance of patency, and treatment of complications. Reported re-intervention rates have varied across studies, device used, and patient populations, ranging from 0.46 to 2.7 per patient-year. While percutaneous arteriovenous fistula creation shows promise in terms of technical success rates, patency, and patient satisfaction, the rate of re-interventions adds to the overall procedural burden and may impact cost-effectiveness. |
format | Article |
id | doaj-art-125d7a8b317f45ed994f1cc54a0562c0 |
institution | Kabale University |
issn | 2542-7075 2542-7083 |
language | English |
publishDate | 2025-01-01 |
publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
record_format | Article |
series | The Arab Journal of Interventional Radiology |
spelling | doaj-art-125d7a8b317f45ed994f1cc54a0562c02025-01-29T00:28:22ZengThieme Medical and Scientific Publishers Pvt. Ltd.The Arab Journal of Interventional Radiology2542-70752542-70832025-01-01090100100510.1055/s-0044-1791222Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula CreationAhmed Kamel Abdel Aal0Juri Bassuner1Husameddin El Khudari2Reema F. Alrasheed3Shahroz Aziz4Mohamed Shahin5Ammar Almehmi6Bridget Kowalczyk7Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Alabama, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesSurgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approaches have led to the development of percutaneous arteriovenous fistula creation. Currently, there are two Food and Drug Administration (FDA) approved systems, namely WavelinQ and Ellipsys. The aim of this article is to review the available literature on the outcomes of percutaneous arteriovenous fistula creation. Studies have reported high technical success rates for both the WavelinQ and Ellipsys systems. However, re-interventions were necessary for maturation, maintenance of patency, and treatment of complications. Reported re-intervention rates have varied across studies, device used, and patient populations, ranging from 0.46 to 2.7 per patient-year. While percutaneous arteriovenous fistula creation shows promise in terms of technical success rates, patency, and patient satisfaction, the rate of re-interventions adds to the overall procedural burden and may impact cost-effectiveness.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791222arteriovenous fistulahemodialysisWavelinQEllipsysre-interventionspatencymaturation |
spellingShingle | Ahmed Kamel Abdel Aal Juri Bassuner Husameddin El Khudari Reema F. Alrasheed Shahroz Aziz Mohamed Shahin Ammar Almehmi Bridget Kowalczyk Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation The Arab Journal of Interventional Radiology arteriovenous fistula hemodialysis WavelinQ Ellipsys re-interventions patency maturation |
title | Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation |
title_full | Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation |
title_fullStr | Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation |
title_full_unstemmed | Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation |
title_short | Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation |
title_sort | early and midterm outcomes of percutaneous arteriovenous fistula creation |
topic | arteriovenous fistula hemodialysis WavelinQ Ellipsys re-interventions patency maturation |
url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791222 |
work_keys_str_mv | AT ahmedkamelabdelaal earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT juribassuner earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT husameddinelkhudari earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT reemafalrasheed earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT shahrozaziz earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT mohamedshahin earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT ammaralmehmi earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation AT bridgetkowalczyk earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation |